Mineralys Therapeutics, Inc. Common Stock (MLYS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for MLYS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 220 institutions reported holding MLYS, with 99.6 million shares worth $2.7 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Catalys Pacific | 7,903,838 | $213M | UNCHANGED |
| RA Capital Management | 7,692,750 | $208M | UNCHANGED |
| BlackRock | 5,887,038 | $159M | INCREASED |
| Samsara Biocapital | 5,871,018 | $158M | UNCHANGED |
| FMR | 4,511,689 | $122M | DECREASED |
Full institutional holdings, insider history, and congressional trades for Mineralys Therapeutics, Inc. Common Stock on SentiSense.